Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674346011 | Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3674347019 | Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4592271000052110 | disopyramid (som disopyramidfosfat) 150 milligram, depåtablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Some | ||
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Is a | Disopyramide-containing product in oral dose form | false | Inferred relationship | Some | ||
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Disopyramide (substance) | true | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Has precise active ingredient | Disopyramide phosphate | true | Inferred relationship | Some | 1 | |
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Is a | Disopyramide only product in oral dose form | true | Inferred relationship | Some | ||
| Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR